Les Philippines expliquent pourquoi la levée de l’interdiction du vaccin Dengvaxia n’est pas à l’ordre du jour. On ne peut que se réjouir de la grande prudence de Francisco Duque (médecin, secrétaire en exercice au Département de la Santé) dans cette affaire.
Duque says reconsideration of Dengvaxia vaccination program not on the table July 25, 2019
AMID THE declaration of a nationwide dengue alert, Secretary Francisco T. Duque III said the Department of Health (DoH) is not considering just yet a possible revival of the controversial Dengvaxia vaccination program.
“We need to study the recommendation… because there is no specific test that would exactly prove that a person has been infected by dengue,” he said during a visit to Iloilo City Thursday.
He emphasized that risks should be balanced with many other factors, noting that those who can benefit from the Dengvaxia vaccine are only those with prior exposure to the dengue virus.
Mr. Duque explained that the available dengue test “cross-reacts” with other viruses like Chikungunya and Zika virus.
“Remember the test cross reacts with other viruses, so it could be Chikungunya, Japanese encephalitis, it could be Zika virus, and I heard it cross reacts with measles virus. So having said that, if it is positive, you are not sure if it’s positive of dengue virus,” he said.
The DoH’s Dengvaxia vaccination program has been cancelled and the vaccine banned in the Philippine market since last year following allegations of related deaths among children who received the vaccine.
https://www.bworldonline.com/duque-says-reconsideration-of-dengvaxia-vaccination-program-not-on-the-table-just-yet/